Cook, Joseph; Golec, Joseph; Vernon, John; Pink, George - In: International Journal of the Economics of Business 18 (2011) 2, pp. 225-238
Drug innovation relies on cumulative, path-dependent, incremental research and development (R&D). In oncology, path …-dependence impacts the decisions of oncology pharmaceutical producers, consumers, and insurers/payers. This study illustrates how real … value. If CER were interpreted this way, its widespread use could reduce oncology R&D, and reduce intermediate innovations …